One in five European small biopharmaceutical companies faces the rick of bankruptcy by the end of 2009. the situation could worsen if the economic downturn continues into 2010, warns the European Biopharmaceutical Enterprise (EBE).
Emmanuelle Voisin, Linda Lebon
European Biotech sector struggles to survive funding crisis, Monthly, June 2009
2009 – The Center Watch
Download the full publication now
Fill in the form to download the content
publication by
Emmanuelle M. Voisin, PhD
Founder and CEO
Dr. Emmanuelle Voisin founded Voisin Consulting Life Sciences (VCLS) in 1997. The firm has become a leading advisor to Biotech,…
View profile
all our resources 
